Walgreens Boots Alliance (NASDAQ:WBA) Shares Down 3.4%

Walgreens Boots Alliance, Inc. (NASDAQ:WBA)’s stock price fell 3.4% during mid-day trading on Thursday . The company traded as low as $45.65 and last traded at $45.65. 118,223 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 5,720,438 shares. The stock had previously closed at $47.26.

Several research analysts have recently weighed in on the stock. TheStreet upgraded shares of Walgreens Boots Alliance from a “c+” rating to a “b-” rating in a report on Monday, October 4th. Credit Suisse Group reaffirmed a “hold” rating and issued a $48.00 price objective on shares of Walgreens Boots Alliance in a research report on Friday, September 24th. Robert W. Baird reissued a “buy” rating and set a $68.00 price target on shares of Walgreens Boots Alliance in a research report on Friday, September 3rd. Truist reduced their price objective on Walgreens Boots Alliance from $58.00 to $52.00 and set a “hold” rating on the stock in a research note on Friday, July 2nd. Finally, Wolfe Research restated a “hold” rating and set a $57.00 price objective on shares of Walgreens Boots Alliance in a research note on Friday, July 2nd. Twelve equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and an average target price of $52.81.

The stock has a market capitalization of $42.89 billion, a price-to-earnings ratio of 17.90, a P/E/G ratio of 1.41 and a beta of 0.49. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.53 and a current ratio of 0.77. The company has a fifty day simple moving average of $48.70 and a 200 day simple moving average of $50.83.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 14th. The pharmacy operator reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.15. Walgreens Boots Alliance had a return on equity of 20.79% and a net margin of 1.66%. The firm had revenue of $34.26 billion during the quarter, compared to analyst estimates of $33.39 billion. During the same period in the previous year, the company posted $1.02 EPS. The company’s revenue for the quarter was up 12.8% on a year-over-year basis. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 4.75 earnings per share for the current fiscal year.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Stonebridge Capital Advisors LLC purchased a new stake in Walgreens Boots Alliance in the first quarter worth about $27,000. Loomis Sayles & Co. L P bought a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $33,000. Red Door Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the second quarter valued at approximately $35,000. Centerpoint Advisors LLC grew its position in Walgreens Boots Alliance by 203.8% in the 2nd quarter. Centerpoint Advisors LLC now owns 711 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 477 shares during the period. Finally, Strategic Blueprint LLC purchased a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth $38,000. 55.65% of the stock is currently owned by institutional investors and hedge funds.

About Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance, Inc engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services.

Featured Story: What is Cost of Goods Sold (COGS)?

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.